Back to companies

Forte Biosciences Inc: Overview

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

Select Item

Forte Biosciences Inc (Forte Biosciences) is a biopharmaceutical company that develops and commercializes product candidates for the treatment of skin. The company offers lead product candidate such as FB-102. FB-102 is used for the for the treatment of autoimmune diseases such as Vitiligo and Alopecia Areata (AA). Alopecia Areata nonscarring hair loss generally on the scalp but can also other areas of the body. Vitiligo is an autoimmune disease in which the immune system attack melanocytes​. Its services include clinical trials. The company has operations across the US. Forte Biosciences is headquartered in Torrance, California, the US.

 Gain a 360-degree view of Forte Biosciences Inc and make more informed decisions for your business Gain a 360-degree view of Forte Biosciences Inc and make more informed decisions for your business Contact Us
Headquarters United States of America
Address 3060 Pegasus Park Drive, Building 6, Dallas, Texas, 75247
Website www.fortebiorx.com/home/default.aspx
Telephone 1 310 6186994
No of Employees 9
Industry Pharmaceuticals and Healthcare
Ticker Symbol & Exchange FBRX (NASD)
EPS XYZ
Net Income (2022) XYZ -126.8% (2022 vs 2021)
Market Cap* $23.0M
Net Profit Margin (0 vs) XYZ 0.0% (2022 vs 2021)
   
* As of and is in US$
View Forte Biosciences Inc financials
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Contact Us

Forte Biosciences Inc premium industry data and analytics

11+

Clinical Trials

Determine Forte Biosciences Inc go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

10+

Pipeline Drugs

Identify which of Forte Biosciences Inc’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

7

Catalyst Calendar

Proactively evaluate Forte Biosciences Inc’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

4

Insights

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

2

Regulatory Milestones

Track drug and patent expiries along with geographies impacted.

Products and Services

Products Services
Pipeline Clinical Trials
FB-102 (Treatment of Skin Disease)
Understand Forte Biosciences Inc portfolio and identify potential areas for collaboration Understand Forte Biosciences Inc portfolio and identify potential areas for collaboration Contact Us
Image for loader

Competitor Comparison

Key Parameters Forte Biosciences Inc Aclaris Therapeutics Inc Abeona Therapeutics Inc Acura Pharmaceuticals Inc Talphera Inc
Headquarters United States of America United States of America United States of America United States of America United States of America
City Dallas Wayne Cleveland Palatine San Mateo
State/Province Texas Pennsylvania Ohio Illinois California
No. of Employees 9 91 84 14 15
Entity Type Public Public Public Public Public
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Contact Us
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Contact Us
Executives
Name Position Board Since Age
Paul A. Wagner, Ph.D Chairman; Chief Executive Officer; Director Executive Board 2018 -
Antony A. Riley Chief Financial Officer Senior Management 2020 -
Christopher Roenfeldt Chief Operating Officer Senior Management 2020 -
Steven Ruhl Chief Technology Officer Senior Management 2021 -
Hubert Chen President; Chief Scientific Officer Senior Management 2018 -
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Gain insight into Forte Biosciences Inc key executives to enhance your sales strategy Gain insight into Forte Biosciences Inc key executives to enhance your sales strategy Contact Us
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer